Collaborative Research Using Biosamples from T1D Clinical Studies

May 2022 Council

Lead Division/Office


Point(s) of Contact

Beena Akolkar, Ph.D.; Lisa Spain, Ph.D.

Executive Summary

This initiative will support ancillary studies using samples from participating type 1 diabetes clinical trials and studies. These studies are expected to generate scientific discoveries on type 1 diabetes primary pathogenesis and on biomarkers of disease progression or clinical responses to interventions leading to improved prevention and cure of type 1 diabetes. Methods should be state of the art, with validated performance. Where appropriate, a strong emphasis will be placed on highly collaborative projects, designed to maximize biomarker discovery and validation from limited sample resources.